Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1129 TLR2 and IFNγ synergize to enhance CXCL10 production, tumor-infiltrating lymphocytes, and growth control in triple negative breast cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
